Document is current
Any future updates will be listed below
-
Authors
van Gogh, Merel
Louwers, Jonas M.
Celli, Anna
Gräve, Sanne
Viveen, Marco C.
Bosch, Sofie
de Boer, Nanne K. H.
Verheijden, Rik J.
Suijkerbuijk, Karijn P. M.
Brand, Eelco C.
Top, Janetta
Oldenburg, Bas
de Zoete, Marcel R.
- License Information
-
More Information
Article History
Received: 29 May 2024
Accepted: 2 September 2024
First Online: 21 October 2024
Declarations
:
: Informed consent for the participation and fecal sample collection was provided by donors prior to enrolment. The sample collection was approved by the VU University Medical Center (Medical Ethical Review Committee number 2016.135) and the University Medical Center Utrecht (Medical Ethical Review Committee numbers TC-bio 18–123 and TC-bio 23–200).
: N.K.H.d.B has served as a speaker for AbbVie and MSD and has served as consultant and principal investigator for TEVA Pharma BV and Takeda. N.K.H.d.B has received a (unrestricted) research grant from Dr. Falk, TEVA Pharma BV, MLDS and Takeda (not related to the submitted work). K.P.M.S. has a consulting/advisory relationship with Abbvie and Sairopa. K.P.M.S. has received research funding from TigaTx, Bristol Myers Squibb, Philips, Genmab and Pierre Fabre (all paid to institution and not related to the submitted work. B.O. has received funding from Takeda, Pfizer, Galapagos, Ferring, Celltrion, BMS, and AbbVie (not related to the submitted work), and served on the advisory boards of Takeda, Galapagos, Janssen, AbbVie, BMS, and Ferring. M.R.d.Z. is an inventor on patents for IgA-SEQ.
